Exagen Inc. Common Stock
Market Cap
120M
Short interest (May 15)
3.0%
Net Short (Jun 03 ): -0.1%
Borrow Fee
0.46%
↓ 5.1%
Available Shares
4M
↑ 33.2%
Price Chart
Company Overview
Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.